Does ILOPROST Cause Neoplasm malignant? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Neoplasm malignant have been filed in association with ILOPROST (AURLUMYN). This represents 0.2% of all adverse event reports for ILOPROST.
10
Reports of Neoplasm malignant with ILOPROST
0.2%
of all ILOPROST reports
6
Deaths
4
Hospitalizations
How Dangerous Is Neoplasm malignant From ILOPROST?
Of the 10 reports, 6 (60.0%) resulted in death, 4 (40.0%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ILOPROST. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does ILOPROST Cause?
Death (1,369)
Dyspnoea (662)
Headache (353)
Cough (284)
Pulmonary arterial hypertension (284)
Hospitalisation (281)
Fatigue (280)
Dizziness (225)
Pneumonia (224)
Pulmonary hypertension (216)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which ILOPROST Alternatives Have Lower Neoplasm malignant Risk?
ILOPROST vs IMATINIB
ILOPROST vs IMBRUVICA
ILOPROST vs IMDEVIMAB
ILOPROST vs IMEGLIMIN
ILOPROST vs IMETELSTAT